Off-pathway aggregation can inhibit fibrillation at high protein concentrations.

Ribosomal protein S6 fibrillates readily at slightly elevated temperatures and acidic pH. We find that S6 fibrillation is retarded rather than favored when the protein concentration is increased above a threshold concentration of around 3.5mg/mL. We name this threshold concentration C(FR), the concentration at which fibrillation is retarded. Our data are consistent with a model in which this inhibition is due to the formation of an off-pathway oligomeric species with native-like secondary structure. The oligomeric species dominates at high protein concentrations but exists in dynamic equilibrium with the monomer so that seeding with fibrils can overrule oligomer formation and favors fibrillation under C(FR) conditions. Thus, fibrillation competes with formation of off-pathway oligomers, probably due to a monomeric conversion step that is required to commit the protein to the fibrillation pathway. The S6 oligomer is resistant to pepsin digestion. We also report that S6 forms different types of fibrils dependent on protein concentration. Our observations highlight the multitude of conformational states available to proteins under destabilizing conditions.

[1]  K. Chung,et al.  Dequalinium-induced Protofibril Formation of α-Synuclein* , 2006, Journal of Biological Chemistry.

[2]  J. Hofrichter Kinetics of sickle hemoglobin polymerization. III. Nucleation rates determined from stochastic fluctuations in polymerization progress curves. , 1986, Journal of molecular biology.

[3]  D. Otzen,et al.  Amyloid—a state in many guises: Survival of the fittest fibril fold , 2007, Protein science : a publication of the Protein Society.

[4]  A. Minton,et al.  A simple semiempirical model for the effect of molecular confinement upon the rate of protein folding. , 2006, Biochemistry.

[5]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[6]  Dennis Claessen,et al.  A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. , 2003, Genes & development.

[7]  Jesper Søndergaard Pedersen,et al.  Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. , 2004, Journal of molecular biology.

[8]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[9]  Scott J. Hultgren,et al.  Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.

[10]  D. Otzen,et al.  Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  V. Uversky,et al.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.

[12]  M. Proctor,et al.  Structural changes in the transition state of protein folding: alternative interpretations of curved chevron plots. , 1999, Biochemistry.

[13]  L. Serpell,et al.  Alzheimer's amyloid fibrils: structure and assembly. , 2000, Biochimica et biophysica acta.

[14]  Kenneth A. Johnson,et al.  Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data. , 2009, Analytical biochemistry.

[15]  P. Lansbury,et al.  Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? , 2002, Biochemistry.

[16]  Raimon Sabaté,et al.  Evidence of the existence of micelles in the fibrillogenesis of beta-amyloid peptide. , 2005, The journal of physical chemistry. B.

[17]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[18]  A. Villaverde,et al.  Amyloid-like properties of bacterial inclusion bodies. , 2005, Journal of molecular biology.

[19]  E. Powers,et al.  The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration". , 2006, Biophysical journal.

[20]  David Eisenberg,et al.  In Brief , 2009, Nature Reviews Neuroscience.

[21]  M. Fändrich,et al.  Thermodynamic analysis of the aggregation propensity of oxidized Alzheimer's β‐amyloid variants , 2005, Protein science : a publication of the Protein Society.

[22]  Conformational detours during folding of a collapsed state. , 2005, Biochimica et biophysica acta.

[23]  S. Becker,et al.  Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Philip J. Thomas,et al.  A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation , 2005, Journal of Biological Chemistry.

[25]  V. Uversky,et al.  Elucidation of the Molecular Mechanism during the Early Events in Immunoglobulin Light Chain Amyloid Fibrillation , 2002, The Journal of Biological Chemistry.

[26]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[27]  D. Otzen,et al.  Amyloid adhesins are abundant in natural biofilms. , 2007, Environmental microbiology.

[28]  E. Powers,et al.  Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation. , 2008, Biophysical journal.

[29]  J. Duhamel,et al.  Concentration effect on the aggregation of a self-assembling oligopeptide. , 2003, Biophysical journal.

[30]  F. Chiti,et al.  Rapid oligomer formation of human muscle acylphosphatase induced by heparan sulfate , 2012, Nature Structural &Molecular Biology.

[31]  D. Otzen,et al.  Salt-induced detour through compact regions of the protein folding landscape. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[33]  F. Vollrath,et al.  Amyloidogenic nature of spider silk. , 2002, European journal of biochemistry.

[34]  J. Gerrard,et al.  Formation of amyloid-like fibrils by ovalbumin and related proteins under conditions relevant to food processing. , 2007, Journal of agricultural and food chemistry.

[35]  V. Uversky,et al.  The effect of macromolecular crowding on protein aggregation and amyloid fibril formation , 2004, Journal of molecular recognition : JMR.

[36]  M. Westwater On the Renormalization of Feynman Integrals , 1969, 1969.

[37]  M. Fändrich,et al.  FTIR reveals structural differences between native β‐sheet proteins and amyloid fibrils , 2004, Protein science : a publication of the Protein Society.

[38]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[39]  D. Brems,et al.  Inverse Relationship of Protein Concentration and Aggregation , 2002, Pharmaceutical Research.

[40]  P. Pradipasena,et al.  Effect of concentration on apparent viscosity of a globular protein solution , 1977 .

[41]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[42]  Jesper Søndergaard Pedersen,et al.  The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. , 2006, Journal of molecular biology.

[43]  V. Uversky,et al.  Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein. , 2008, Journal of molecular biology.

[44]  R. Wetzel,et al.  Polymorphism in the intermediates and products of amyloid assembly. , 2007, Current opinion in structural biology.

[45]  D. Nečas,et al.  Gwyddion: an open-source software for SPM data analysis , 2012 .

[46]  M. Leone,et al.  Secondary nucleation and accessible surface in insulin amyloid fibril formation. , 2008, The journal of physical chemistry. B.

[47]  S. Müller,et al.  Multiple Assembly Pathways Underlie Amyloid-β Fibril Polymorphisms , 2005 .

[48]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[49]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.